Coriolis Pharma Research GmbH

Coriolis Pharma Research GmbH is a globally operating contract research and development organization (CRDO) headquartered in Martinsried, 49. The company specializes in providing comprehensive services for the development of biopharmaceutical drug products, including formulation development, analytical services, and manufacturing support. With a focus on biologics such as antibodies, peptides, gene therapies, and vaccines, Coriolis Pharma offers expertise in both liquid and lyophilized drug products under R&D and GMP conditions. Their services encompass early-phase development, analytical method development, stability testing, and lyophilization process development. Coriolis Pharma's state-of-the-art facilities and experienced scientific team ensure that clients receive high-quality, compliant, and timely services to accelerate the development of their drug products. The company's commitment to innovation and excellence has established it as a trusted partner in the biopharmaceutical industry.